28 results
8-K
EX-10.1
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
applicable local, state and federal environmental Laws (including Laws relating to the use, disposal or release of hazardous or toxic substances … or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances), and all applicable Laws enforced
8-K/A
EX-99.3
1j93j551kto6ited
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
425
EX-2.1
jplj1viqu30
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
2u2439 oo99o4ne4u
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-1.1
jb9g9ekq5i2mxqm8
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-99.1
3x56nw6g zft89lubzoo
13 Sep 21
Diffusion Pharmaceuticals Issues Letter to Shareholders
4:09pm
8-K
EX-1.1
d21h444
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-10.1
6is c2yxw1qs
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.1
1yjlm5o 9f1ud5oqgr3y
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-10.2
mwe czbx29ce
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-10.1
ej2 g6yg8vgjq
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm